This inventor holds 1 USPTO granted patent. Top assignees: Celdara Medical, LLC, Dartmouth College. Active years: 2026.
Company Filing History:
1 out of 3 
1 out of 706 
Years Active: 2026
Title: Michael Whitfield: Innovator in Chimeric Antigen Receptors
Introduction
Michael Whitfield is a notable inventor based in Etna, NH (US). He has made significant contributions to the field of biomedical engineering, particularly in the development of chimeric antigen receptors (CARs). His work focuses on innovative solutions for treating fibrotic, inflammatory, and autoimmune conditions.
Latest Patents
Whitfield holds a patent for "Chimeric antigen receptors that target molecules on disease-associated macrophages and methods related thereto." This invention provides CARs, nucleic acid sequences encoding a CAR, and vectors that comprise these sequences. The CARs are designed to bind to target molecules expressed on disease-associated macrophages (DAMs) or those that are over- or aberrantly expressed in fibrosis. The invention also includes methods for treating various diseases using CAR-expressing cells and pharmaceutical compositions.
Career Highlights
Throughout his career, Michael Whitfield has worked with prominent organizations such as Celdara Medical, LLC and Dartmouth College. His experience in these institutions has allowed him to advance his research and contribute to the scientific community significantly.
Collaborations
Some of his notable coworkers include Patricia Pioli and Charles L. Sentman. Their collaborative efforts have further enhanced the impact of Whitfield's innovations in the field.
Conclusion
Michael Whitfield's work in developing chimeric antigen receptors represents a significant advancement in medical technology. His contributions are paving the way for new treatments for complex diseases, showcasing the importance of innovation in healthcare.